ZOM Zomedica Corp. Stock Quote

ZOM [AMEX]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	-	EPS (ttm)	-0.06	Insider Own	0.30%	Shs Outstand	972.02M	Perf Week	-24.41%
Market Cap	920.01M	Forward P/E	-	EPS next Y	0.00	Insider Trans	-33.19%	Shs Float	921.62M	Perf Month	-59.69%
Income	-16.90M	PEG	-	EPS next Q	0.00	Inst Own	6.70%	Short Float	5.56%	Perf Quarter	-13.18%
Sales	-	P/S	-	EPS this Y	75.10%	Inst Trans	62.53%	Short Ratio	0.46	Perf Half Y	926.18%
Book/sh	0.09	P/B	9.41	EPS next Y	100.00%	ROA	-42.10%	Target Price	1.20	Perf Year	424.21%
Cash/sh	0.06	P/C	14.84	EPS next 5Y	-	ROE	-67.60%	52W Range	0.06 - 2.91	Perf YTD	267.13%
Dividend	-	P/FCF	-	EPS past 5Y	8.90%	ROI	-	52W High	-70.91%	Beta	0.31
Dividend %	-	Quick Ratio	31.00	Sales past 5Y	-	Gross Margin	-	52W Low	1248.09%	ATR	0.22
Employees	19	Current Ratio	31.00	Sales Q/Q	-	Oper. Margin	-	RSI (14)	31.55	Volatility	18.85% 15.17%
Optionable	No	Debt/Eq	0.05	EPS Q/Q	73.00%	Profit Margin	-	Rel Volume	0.72	Prev Close	0.85
Shortable	Yes	LT Debt/Eq	0.02	Earnings	-	Payout	-	Avg Volume	110.84M	Price	0.85
Recom	2.00	SMA20	-38.54%	SMA50	-54.31%	SMA200	29.91%	Volume	0	Change	0.00%

Apr-15-21 06:01AM	Zomedica to Build Direct Sales Force for TRUFORMA® Platform GlobeNewswire -13.71%
Apr-02-21 09:48AM	Pounce on This Pullback in the Zomedica Share Price InvestorPlace
Mar-16-21 06:00AM	Zomedica Announces First Commercial Sale of Its Truforma® Platform GlobeNewswire -9.24%
Mar-08-21 06:05AM	Zomedica Retires Preferred Shares GlobeNewswire +5.62%
Feb-26-21 04:15PM	Zomedica Corp. Announces Year End 2020 Financial Results GlobeNewswire
11:01AM	All Bets are Off Whether Zomedica Stock Grows Into Its Valuation InvestorPlace
10:38AM	How to Navigate the Questionable Future of the Top 10 Meme Stocks InvestorPlace
Feb-18-21 10:16AM	Here are the tough questions Congress needs to ask about GameStop today Yahoo Finance Video
Feb-16-21 12:02PM	What the GameStop Congressional hearing will reveal to retail investors Yahoo Finance -7.78%
11:37AM	Zomedica Corp. Announces Full Exercise of Over-Allotment Option by Underwriter GlobeNewswire
Feb-12-21 11:03AM	TransEnterix Stock Has Potential, But Wait for a Pullback InvestorPlace
Feb-11-21 12:18PM	Zomedica Corp. Announces Closing of $173.5 Million Bought Deal GlobeNewswire
Feb-09-21 08:16AM	Zomedica stock tumbles on heavy volume after public stock offering upsized 7-fold 'due to demand' MarketWatch -14.07%
Feb-08-21 11:00PM	Zomedica Corp. Increases Previously Announced Bought Deal Offering of Common Shares to $173.5 Million GlobeNewswire +41.36%
05:01PM	Zomedica Corp. Announces $25.0 Million Bought Deal Offering of Common Shares GlobeNewswire
Feb-05-21 04:09PM	Zomedica Is a High-Risk Trade, Not a Long-Term Investment InvestorPlace +27.33%
Feb-01-21 01:03PM	Zomedica Stock Is up 330% in One Month; Is There Room for More Upside? TipRanks +19.57%
Jan-25-21 06:10AM	Zomedica Signs TRUFORMA Distribution Agreement With Miller Veterinary Supply GlobeNewswire +6.67%
Jan-18-21 06:15AM	Zomedica CEO Issues Shareholder Letter as TRUFORMA Nears Commercialization GlobeNewswire
Jan-15-21 06:23PM	Jeremy Granthams Bubble Forecast Is an Outlier. Is He Right? Barrons.com
Jan-12-21 05:53PM	Penny stock Zomedica jumps 250% after someone paid Netflix star Carole Baskin $299 for a mention Yahoo Finance +39.78%
Jan-04-21 06:10AM	Zomedica Appoints Robert Cohen CEO as Company Nears Commercialization of TRUFORMA GlobeNewswire +51.78%
Dec-15-20 08:53AM	Zomedica to Remain Domiciled in Canada GlobeNewswire
Dec-07-20 06:01AM	Zomedica Completes Internal Launch Team for Upcoming TRUFORMA Commercialization GlobeNewswire
Nov-28-20 08:50PM	Is Zomedica Corp. (ZOM) A Good Stock To Buy Now? Insider Monkey
Nov-18-20 12:38PM	Is Zomedica Stock a Buy Right Now? This Analyst Says Yes TipRanks -12.84%
Nov-13-20 06:00AM	Zomedica Sets March 30, 2021 as Expected Commercialization Date for TRUFORMA GlobeNewswire +18.38%
Nov-12-20 06:30AM	Zomedica Announces Third Quarter 2020 Financial Results GlobeNewswire
Oct-26-20 09:25AM	Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Special Virtual-Only Meeting GlobeNewswire
Oct-02-20 05:05PM	Zomedica Announces Name Change GlobeNewswire
Sep-25-20 11:00AM	Zomedica Announces Shareholder Meeting Voting Results GlobeNewswire +5.50%
Sep-14-20 05:44PM	Zomedica Announces Letter to Shareholders in Connection With Annual and Special Virtual-Only Meeting GlobeNewswire
Sep-10-20 06:55AM	Zomedica Announces Presentation at Upcoming H.C. Wainwright Virtual Global Investment Conference GlobeNewswire
Sep-08-20 06:55AM	Zomedica to Develop Gastrointestinal Testing Panel for TRUFORMA GlobeNewswire
Aug-27-20 06:55AM	Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Annual and Special Virtual-Only Meeting GlobeNewswire
Aug-10-20 04:15PM	Zomedica Announces Second Quarter 2020 Financial Results GlobeNewswire
Aug-07-20 06:55AM	Zomedica Adds Two New Directors To Board Annual Meeting Materials Availability GlobeNewswire
Aug-03-20 06:55AM	Zomedica Announces Management Change GlobeNewswire
Jul-21-20 04:01PM	Successful Remote Installation of TRUFORMA GlobeNewswire
04:01PM	Successful Remote Installation of TRUFORMA GlobeNewswire
Jul-07-20 04:01PM	Zomedica Pharmaceuticals Corp. Closes $30 Million Public Offering GlobeNewswire
Jul-01-20 10:30PM	Zomedica Pharmaceuticals Corp. Announces $30 Million Public Offering GlobeNewswire -5.59%
04:04PM	Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering GlobeNewswire
Jun-30-20 09:00AM	Zomedica (ZOM) in Focus: Stock Moves 7.2% Higher Zacks -9.20%
Jun-25-20 09:26AM	PCG Research Announces Publication of Update Report Covering Zomedica Pharmaceuticals Corp. Newsfile +22.11%
Jun-16-20 06:05PM	Zomedica Appoints New Interim CEO to Lead Organization Through Inaugural Product Launch GlobeNewswire
May-29-20 04:05PM	Zomedica Pharmaceuticals Corp. Closes $20 Million Public Offering GlobeNewswire
May-26-20 10:16PM	Zomedica Pharmaceuticals Corp. Announces $20 Million Public Offering GlobeNewswire
May-20-20 04:05PM	Zomedica Completes Verification of Three More Assays for its TRUFORMA Point-of-Care Diagnostic Platform GlobeNewswire
May-11-20 06:55PM	Zomedica Pharmaceuticals Corp (ZOM) Reports Q1 Loss, Lags Revenue Estimates Zacks
04:20PM	Zomedica Announces First Quarter 2020 Financial Results GlobeNewswire
Apr-21-20 06:55AM	Zomedica Completes Verification of its TRUFORMA Point-of-Care Diagnostic Platform and the First Assay, Canine total T4 GlobeNewswire
Apr-13-20 07:15PM	Zomedica Provides Corporate Update GlobeNewswire
Apr-07-20 11:32PM	Zomedica Pharmaceuticals Corp. Announces Pricing of $4.0 Million Public Offering GlobeNewswire
04:01PM	Zomedica Pharmaceuticals Corp. Announces Public Offering GlobeNewswire
Feb-26-20 05:25PM	Zomedica Pharmaceuticals Corp. Announces Year End 2019 Financial Results GlobeNewswire -18.76%
Feb-14-20 04:15PM	Zomedica Announces Completion of $2.5 Million Registered Direct Offering GlobeNewswire
Feb-12-20 08:43AM	Zomedica Announces $2.5 Million Registered Direct Offering GlobeNewswire -35.74%
Feb-11-20 06:55AM	Zomedica Files U.S. Patent Application for Fecal Parasite Detection GlobeNewswire +13.17%
Jan-30-20 06:55AM	Zomedica to Voluntarily Delist its Common Shares from TSX Venture Exchange Effective February 10, 2020 GlobeNewswire
Jan-23-20 06:55AM	Zomedica to Focus on TRUFORMA Commercialization GlobeNewswire
Jan-20-20 06:55AM	Zomedica Successfully Completes Development and Manufacturing Milestones for its Cancer Liquid Biopsy Platform GlobeNewswire
Dec-23-19 04:00PM	Hedge Funds Have Never Been This Bullish On Zomedica Pharmaceuticals Corp. (ZOM) Insider Monkey +5.26%
Dec-03-19 06:55AM	Zomedica Announces Management Changes GlobeNewswire
Nov-13-19 06:55AM	Zomedica Expands ZM-006 Pilot Efficacy Study GlobeNewswire
Nov-12-19 04:53PM	Zomedica Announces Third Quarter 2019 Financial Results GlobeNewswire
Nov-05-19 04:15PM	Zomedica Announces 2019 Annual Meeting Results GlobeNewswire
Oct-31-19 06:55AM	Zomedica Commences Final TRUFORMA Diagnostic Verification Study GlobeNewswire
Oct-03-19 11:27AM	CORRECTION FROM SOURCE: Zomedica Pushes TRUFORMA(TM) Closer To Commercialization, Targeting $2.7 Billion Companion Animal Diagnostics Market Newsfile
Oct-01-19 09:17AM	Zomedica Pushes TRUFORMA (TM) Closer To Commercialization, Targeting $2.7 Billion Companion Animal Diagnostics Market Newsfile -11.14%
Sep-18-19 01:39PM	Do Insiders Own Shares In Zomedica Pharmaceuticals Corp. (CVE:ZOM)? Simply Wall St.
Sep-17-19 06:55AM	Zomedica names Dr. Stephanie Morley President GlobeNewswire
Sep-11-19 09:09AM	PCG Research Announces Publication of Report Covering Zomedica Pharmaceuticals Corp. Newsfile +17.33%
09:00AM	Zomedica to Present at the Fall Investor Summit on Monday, September 16 in New York City ACCESSWIRE
Sep-03-19 06:55AM	Zomedica to Present at RHK Capital 2019 Disruptive Growth Conference, Fall Investor Summit, and Sidoti & Company Fall 2019 Investor Conference GlobeNewswire
Aug-19-19 06:55AM	Animal Health Veteran Johnny D. Powers Joins Zomedica Board of Directors GlobeNewswire
Aug-13-19 08:00AM	Zomedica Inc. Prepares to Launch Veterinarian Diagnostic Device, TRUFORMA(TM); Has Potential to Change Diagnostic Landscape in Animal Health (NYSE American: ZOM) ACCESSWIRE
Aug-08-19 04:08PM	Zomedica Announces Second Quarter 2019 Financial Results GlobeNewswire
Aug-07-19 06:55AM	Zomedica Announces TRUFORMA Assay Updates and R&D Expansion GlobeNewswire
Jul-25-19 06:55AM	Zomedicas Dr. Bonnie Bragdon to Speak at AVMA Convention 2019 on Sunday, August 4 GlobeNewswire
Jul-17-19 06:55AM	Zomedica Announces Initiation of a Digital Data Platform Enhancing its Diagnostic Pipeline GlobeNewswire
Jun-26-19 10:05AM	ZOM: One Instrument; Multiple Solutions Zacks Small Cap Research
Jun-13-19 06:55AM	Zomedica Announces Completion of Initial Development of a Lymphoma Assay for its Canine Cancer Liquid Biopsy Platform GlobeNewswire +10.20%
Jun-12-19 04:35PM	Zomedica to Present at Raymond James Life Sciences and MedTech Conference GlobeNewswire -13.05%
Jun-10-19 06:00AM	Zomedica Announces $7 Million Second Tranche Closing of Preferred Shares GlobeNewswire +6.57%
May-21-19 06:55AM	Zomedica Announces Achievement of Product Development Milestones on its TRUFORMA Point-of-Care Diagnostic Platform GlobeNewswire +12.96%
May-10-19 05:21PM	Zomedica Announces First Quarter 2019 Financial Results GlobeNewswire +6.69%
06:00AM	Zomedica Announces Private Placement of Preferred Shares GlobeNewswire
Mar-26-19 06:00AM	Zomedica Pharmaceuticals Corp. Announces Pricing of $3 Million Underwritten Public Offering of Common Shares GlobeNewswire -43.82%
Mar-25-19 04:01PM	Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering of Common Shares GlobeNewswire -12.38%
Mar-05-19 06:55AM	Zomedica Initiates ZM-006 Pilot Efficacy Study and Provides Corporate Updates GlobeNewswire +6.77%
Feb-26-19 04:05PM	Zomedica Pharmaceuticals Corp. Announces Year End 2018 Financial Results GlobeNewswire
Jan-15-19 06:55AM	Zomedica Appoints Dr. Bonnie Bragdon as Vice President of Veterinary Affairs GlobeNewswire +5.36%
Jan-14-19 06:55AM	Zomedica Announces $4.28 Million Private Placement Closing and Corporate Update GlobeNewswire -7.44%
Dec-20-18 05:23PM	Zomedica Provides Update on Pipeline Development and Announces At-The-Market Offering Program GlobeNewswire +9.32%
Dec-19-18 06:00AM	IncellDx and Zomedica Sign Diagnostic CTC Assay Development Agreement for Canine Cancer PR Newswire -13.87%
Nov-28-18 09:53AM	Qorvo, Zomedica Tie-Up to Enhance Vet Health with BAW Sensors Zacks +12.34%
Nov-27-18 06:51AM	Zomedica Signs Exclusive Agreement with Qorvo Biotechnologies for Global Veterinary Rights to Diagnostic Point-of-Care Platform GlobeNewswire -10.47%
06:50AM	Zomedica Announces $10 Million Private Offering of Common Shares GlobeNewswire
Nov-26-18 07:25AM	Analysis: Positioning to Benefit within Dominion Energy Midstream Partners, LP, Blue Capital Reinsurance, CRH Medical, Friedman Industries, CM Finance, and Zomedica Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire +11.69%

Zomedica Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies. The company is also developing ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination. It has a collaboration agreement with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and with Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
POWERS JOHNNY D	Director	Apr 12	Option Exercise	0.45	750,000	340,000	875,000	Apr 13 11:36 AM
Cotter Ann Marie	CFO and Secretary	Apr 12	Option Exercise	0.16	58,332	9,083	33,332	Apr 13 11:29 AM
Morley Stephanie	President & CMO	Apr 12	Option Exercise	0.34	805,000	272,950	1,959,580	Apr 13 11:33 AM
Cotter Ann Marie	CFO and Secretary	Apr 12	Sale	1.16	58,332	67,473	0	Apr 13 11:29 AM
Morley Stephanie	President & CMO	Apr 12	Sale	1.16	805,000	931,144	1,459,580	Apr 13 11:33 AM
POWERS JOHNNY D	Director	Apr 12	Sale	1.16	750,000	867,525	625,000	Apr 13 11:36 AM
MACLEOD CHRISTOPHER ROSS	Director	Feb 03	Sale	1.10	6,400	7,047	0	Feb 05 04:45 PM
POWERS JOHNNY D	Director	Jul 07	Buy	0.16	625,000	100,000	625,000	Jul 07 04:53 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience